Page 1 of Clinical Trials for VEGF, 971 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy
Last Updated: March 2, 2011
Condition(s): Diabetic Macular Edema
2
Enrolling by invitation
Vascular Endothelial Growth Factor Levels in Ectopic Pregnancy
Last Updated: May 17, 2012
Condition(s): Complication Following Ectopic Pregnancy
3
Recruiting
Prospective Randomized Trial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
Last Updated: November 10, 2011
Condition(s): Exudative Age-related Macular Degeneration
4
Completed
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
Last Updated: January 27, 2012
Condition(s): Macular Degeneration
5
Not yet recruiting
Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?
Last Updated: December 22, 2008
Condition(s): Choroidal Neovascularization; Age-Related Macular Degeneration
6
Completed
Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
Last Updated: June 8, 2011
Condition(s): Diabetic Macular Edema
7
Withdrawn
Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
Last Updated: April 20, 2012
Condition(s): Glioma; Meningioma
8
Active, not recruiting
Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
Last Updated: February 24, 2012
Condition(s): Wet AMD
9
Completed
Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)
Last Updated: April 13, 2012
Condition(s): Macular Degeneration
10
Completed
Angiogenesis Using VEGF-A165/bFGF Plasmid Delivered Percutaneously in No-option CAD Patients; a Controlled Trial
Last Updated: November 27, 2009
Condition(s): Coronary Artery Disease
11
Withdrawn
A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
Last Updated: December 19, 2011
Condition(s): Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Hepatocellular
12
Recruiting
EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction
Last Updated: December 14, 2011
Condition(s): Pre-eclampsia; Intra-uterine Growth Retardation
13
Active, not recruiting
VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Last Updated: April 11, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
14
Active, not recruiting
Extension Study of the Use of Vascular Endothelial Growth Factor (VEGF) Trap-Eye in Wet Age-Related Macular Degeneration
Last Updated: April 3, 2012
Condition(s): Neovascular Age-related Macular Degeneration
15
Completed
Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
Last Updated: June 8, 2011
Condition(s): Macular Degeneration
16
Completed
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
Last Updated: February 20, 2012
Condition(s): Retinal Vein Occlusion
17
Completed
Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer
Last Updated: October 13, 2009
Condition(s): Rectal Cancer
18
Completed
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)
Last Updated: February 27, 2012
Condition(s): Macular Degeneration
19
Active, not recruiting
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
Last Updated: March 28, 2012
Condition(s): Macular Edema Secondary to Central Retinal Vein Occlusion
20
Completed
Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors
Last Updated: September 16, 2009
Condition(s): Messurement Levels of VEGF

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=VEGF

Page 1 of Clinical Trials for VEGF, 971 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About